Releases Details
Exercise of options and PDMR dealing
("
Exercise of options, PDMR dealing and Total Voting Rights
Following the Exercise,
The sales and option exercises were effected pursuant to a Rule 10b5-1 trading plan adopted by
Total voting rights
The 30,000 New Common Stock have been admitted to trading on AIM pursuant to the Block Listing announced by the Company on September 6, 2021. The New Common Stock will rank pari passu with the existing shares of common stock of the Company and will trade in the unrestricted line of Common Stock trading under the symbol MXCT. The total issued stock capital of the Company following the above will be 102,845,612 shares of common stock. Shareholders in the Company may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the stock capital of the Company.
MaxCyte Contacts: US IR Adviser
|
+1 415-937-5400
|
|
Nominated Adviser and Joint Corporate Broker Panmure Gordon Corporate Broking |
+44 (0)20 7886 2500 |
|
|
+44 (0)203 709 5700
|
|
About
Learn more at maxcyte.com and follow us on
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. |
||||||
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
a) |
|
|
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Chief Executive Officer |
||||
b) |
Initial notification /Amendment |
Initial Notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
|
|
||||
b) |
LEI |
54930053YHXULRFCU991 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument Identification code |
$0.01 ordinary shares
US57777K1060 |
||||
b) |
Nature of the transaction |
Exercise of options over Common Stock |
||||
c) |
Price(s) and volume(s) |
$0.04 per Ordinary Share
|
||||
d) |
Aggregated information - Aggregated volume - Price |
30,000 N/A |
||||
e) |
Date of the transaction |
3 to |
||||
f) |
Place of the transaction |
London Stock Exchange - AIM |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. |
||||||
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
a) |
|
|
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Chief Executive Officer |
||||
b) |
Initial notification /Amendment |
Initial Notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
|
|
||||
b) |
LEI |
54930053YHXULRFCU991 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument Identification code |
US57777K1060 |
||||
b) |
Nature of the transaction |
Sale of Common Stock |
||||
c) |
Price(s) and volume(s) |
$0.04 per Ordinary Share
|
||||
d) |
Aggregated information - Aggregated volume - Price |
N/A 30,000 |
||||
e) |
Date of the transaction |
3 to |
||||
f) |
Place of the transaction |
London Stock Exchange - AIM |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the